Precision Medicine Market Size, Industry Trends, Share and Forecast 2019-2025
Identification of biomarkers is very essential to develop and
realize the potential of precision medicine. Researches conducted by the
different research institutes has turned to the proteomics, for developing new
biomarkers. These latest researches have improved the accuracy of the
biomarkers as early diagnosis of the diseases help the physicians to provide
better treatment. Presently, scientists are focusing on the gene expression for
detecting the results of the therapy process. In June 2018, the National Cancer
Institute (NCI) has sponsored a Trial Assigning Individualized Option for
treatment (Rx), or TAILORx. This test enabled the scientists and other
healthcare providers to assign patients to the most appropriate and effective
treatment. Thereby, unfolding growth opportunities for the global
precision medicine market.
The biomarkers test is being utilized to find the risk factor of
the reoccurrence of breast cancer. In 2015, there was an investment made by the
Precision Medical Initiative of around $70 million to the National Cancer
Institute. The investment was made to recognize the different genomic drivers
in cancer and to develop new approaches for the diagnosis of cancer.
To Request a Sample of our Report
on Precision Medicine Market: https://www.omrglobal.com/request-sample/precision-medicine-market
In October 2017, the US-based company called Gentris, working in
the field of genomic biomarkers in clinical studies, signed a Memorandum of
Understanding to form a biomarker collaboration with the Shanghai Institutes of
Preventative Medicine. This partnership was aimed to discover new biomarkers.
It may result in the development of the effective precision medicine. Thus,
likely to expand the market size for global precision medicine market.
Moreover, in April 2017, Oxford Cancer Biomarkers with the
collaboration of My-BioMed Biotechnology (MBM) expanded the use of three of its
in-vitro diagnostic tests for colorectal cancer into China. Increasing
personalized treatment has focused on pharmaceutical companies for investments
in biomarkers. These three tests have been developed for colorectal cancer by
OCB (Oxford Cancer Biomarker) and are intended for distributing personalized
medicine and are part of a portfolio.
This strategic collaboration will permit patients across China to
access OCB’s suite of precision oncology diagnostic technologies and specific
needs of the Chinese market. This enables in building a robust product pipeline
of diagnostics exactly aimed at the population of China.
Current Market Trends Covered in
the Global Precision Medicine Market Report
- On the basis of the application segment, the oncology
application segment is estimated to hold the maximum market share over the
forecast period.
- Asia-Pacific is estimated to gain maximum traction in the
global precision medicine industry during the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of Precision Medicine Market is Available
at: https://www.omrglobal.com/industry-reports/precision-medicine-market
Global Precision Medicine Market
Segmentation
By Technology
- Genomics
- Transcriptomics
- Epigenomics
By Application
- Oncology
- Neurology
- Immunology
- Others (Respiratory)
By End-Use
- Pharmaceutical Companies
- Diagnostic Companies
- Healthcare IT Companies
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- Rest oF APAC
Rest of The World
- Latin America
- Middle East and Africa
Company Profiles
- Abbott Laboratories Inc.
- Almac Group
- AstraZeneca PLC
- Asuragen Inc.
- Biocrates Life Sciences AG
- Bristol-Myers Squibb Co.
- Eagle Genomics Ltd.
- Hoffmann La Roche Ltd.
- General Electric Co.
- GlaxoSmithKline PLC
- Illumina Inc.
- Intomics AS
- Laboratory Corp. of America Holdings
- Leucine Rich Bio Pvt. Ltd.
- Medtronic PLC
- Menarini Silicon Biosystems S.p.a.
- Nanostring Technologies
- Novartis AG
- PerkinElmer Inc.
- Pfizer Inc.
- Qiagen NV
- Quest Diagnostics Inc.
- Teva Pharmaceutical Industries Ltd.
- Thermo Fischer Scientific Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented
into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before
and after purchasing your report.
For More Customized Data, Request
for Report Customization @ https://www.omrglobal.com/report-customization/precision-medicine-market
About Orion Market
Research
Orion Market Research (OMR) is a market research and consulting
company known for its crisp and concise reports. The company is equipped with
an experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For More Information, Visit Orion Market Research
Media Contact:
Company Name: Orion
Market Research
Contact Person: Mr.
Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91
7803040404
Comments
Post a Comment